MedTest Announces Acquisition of Clinitox Diagnostix

27 Oct 2014

Industry news

MedTest Holdings ("MedTest"), the parent company of MedTest DX and Pointe Scientific, has signed a definitive agreement to acquire Clinitox Diagnostix located in Mississauga, Ontario, Canada. MedTest is an in-vitro diagnostics company providing automated, fast and cost-effective blood and urine testing solutions for diabetes, cardiovascular screening and wellness testing.

Clinitox Diagnostix was founded in 2010 by Howard Lee. Clinitox Diagnostix provides drugs of abuse confirmatory testing capabilities via liquid chromatography/mass spectrophotometry (LC/MS) instrumentation and associated reagents and consumables as pre-packaged kits. Implementation consulting provides the customer with on-site assistance in setting up their LC/MS testing and developing the standard operating procedures enabling the laboratory to initiate testing sooner and reduce costly start–up costs.

Hanjoon Ryu, CEO of MedTest, stated: "The addition of Clinitox Diagnostix to our portfolio enables us to become a highly differentiated provider of extensive solutions in the drugs of abuse testing market. Now we can provide the laboratory with confirmatory drugs of abuse testing capability in addition to the urine drugs of abuse screening testing that can be performed on the Mindray™ BS-200 and BS-480 Chemistry Analyzers. Our clinical expertise in the drugs of abuse testing market meets both individual laboratory testing needs as well as the needs of the growing hub-and-spoke regional toxicology networks."

In addition to manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets, MedTest is the exclusive US distributor of the Mindray™ floor model BS–480 Chemistry Analyzer and the bench–top BS–200 Chemistry Analyzer. The acquisition of Clinitox enables MedTest to provide a more integrated service offering of innovative instruments with proven quality reagents, superior customer support and recognized economic advantages.

Links

Tags

Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Toxicology / Drugs of Abuse TestingToxicology and Drugs of Abuse Testing is the investigation into toxic and illegal substances found at the scene of a crime or from a suspect and / or victim associated with a scene of a crime. Analyzers, immunoassays and drugs of abuse test kits and presumptive test kits are an essential aspect of toxicology investigation.Clinical ChemistryClinical chemistry involves the analysis of bodily fluids, like blood and urine, to diagnose and monitor diseases. Tests in clinical chemistry provide critical information for patient care and treatment decisions. Explore clinical chemistry tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Drugs of AbuseA drug of abuse is a drug that has been taken for non-medical purposes. Such drugs can have mind-altering effects, with some causing dependence and addiction.